Immune correlates of reactivation tuberculosis
再激活结核病的免疫相关性
基本信息
- 批准号:8442696
- 负责人:
- 金额:$ 6.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-20 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAntibodiesAntigensBiologicalCBA/J MouseCell physiologyCellsChronicDataDiseaseDisease ProgressionEventGenesGoalsGrantImmuneImmunityIn VitroIndividualInfectionInterleukin-10LinkLungMediatingModelingMouse StrainsMusMycobacterium tuberculosisPhenotypePredispositionPreventionProductionRelative (related person)Research PersonnelRoleSourceSpecificityT-LymphocyteTechniquesTuberculosiscytokineimmune functionin vivolymph nodesmacrophagemanmouse modelmycobacterialpreventprogramsreceptorresearch studyresponsetherapeutic developmenttool
项目摘要
DESCRIPTION (provided by applicant): In man, tuberculosis disease is highly associated with increased IL-10 production and the use of murine models has confirmed a critical role for IL-10 in disease progression. In this grant we propose to investigate how IL-10 can influence disease progression using both in vitro and in vivo techniques. We will take advantage of the CBA/J mouse strain which, in similarity to man, can naturally produce abundant IL-10 in vivo during infection with M. tuberculosis. Using the CBA/J mouse strain as our primary model we will determine the mechanism by which increased IL-10 production leads to disease progression by investigating the immune functions that are altered in the presence of this cytokine. In addition to investigating the natural progression of infection in a strain that produces abundant IL-10 we will also administer anti-IL-10R antibodies to determine exactly how IL-10 has a biological influence on disease progression. Furthermore, we will investigate whether blocking the action of IL-10 can reverse the susceptibility phenotype of this particular mouse strain, an event that would have particular relevance to the treatment and prevention of tuberculosis disease in man. The goal of this proposal is to use the CBA/J mouse strain as a tool to determine the in vivo role and relevance of IL-10 during infection with M. tuberculosis. This is best achieved using a mouse model in which abundant IL-10 production has been linked with disease progression. A more fundamental understanding of how IL-10 facilitates disease progression will provide critical information about the factors that contribute to an individual's susceptibility to develop active tuberculosis. Additionally, an understanding of the mechanism(s) by which IL-10 mediates disease progression would aid in the development of therapeutic treatments that may delay or even prevent tuberculosis disease.
描述(由申请人提供):在人类中,结核病与IL-10产生增加高度相关,并且使用鼠模型已证实IL-10在疾病进展中的关键作用。在这项研究中,我们建议使用体外和体内技术研究IL-10如何影响疾病进展。我们将利用CBA/J小鼠品系,其与人相似,在感染M的过程中可以在体内天然产生丰富的IL-10。结核使用CBA/J小鼠品系作为我们的主要模型,我们将通过研究在这种细胞因子存在下改变的免疫功能来确定IL-10产生增加导致疾病进展的机制。除了研究产生大量IL-10的菌株中感染的自然进展外,我们还将施用抗IL-10 R抗体以确切地确定IL-10如何对疾病进展产生生物学影响。此外,我们将研究阻断IL-10的作用是否可以逆转这种特定小鼠品系的易感性表型,这一事件与人类结核病的治疗和预防特别相关。本提案的目标是使用CBA/J小鼠品系作为确定IL-10在感染M期间的体内作用和相关性的工具。结核这是最好的实现使用小鼠模型,其中丰富的IL-10的生产已与疾病进展。对IL-10如何促进疾病进展的更基本的理解将提供有关导致个体易患活动性结核病的因素的关键信息。此外,对IL-10介导疾病进展的机制的理解将有助于开发可能延迟甚至预防结核病的治疗性治疗。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection.
- DOI:10.4049/jimmunol.1202722
- 发表时间:2013-03-15
- 期刊:
- 影响因子:0
- 作者:Cyktor JC;Carruthers B;Kominsky RA;Beamer GL;Stromberg P;Turner J
- 通讯作者:Turner J
Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection.
- DOI:10.1371/journal.pone.0058612
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Cyktor JC;Carruthers B;Beamer GL;Turner J
- 通讯作者:Turner J
Evaluation of a modified interferon-gamma release assay for the diagnosis of latent tuberculosis infection in adult and paediatric populations that enables delayed processing.
- DOI:10.3109/00365548.2010.498021
- 发表时间:2010-12
- 期刊:
- 影响因子:0
- 作者:Wang SH;Powell DA;Nagaraja HN;Morris JD;Schlesinger LS;Turner J
- 通讯作者:Turner J
Blood RNA signatures predict recent tuberculosis exposure in mice, macaques and humans.
- DOI:10.1038/s41598-020-73942-z
- 发表时间:2020-10-09
- 期刊:
- 影响因子:4.6
- 作者:Ault RC;Headley CA;Hare AE;Carruthers BJ;Mejias A;Turner J
- 通讯作者:Turner J
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOANNE TURNER其他文献
JOANNE TURNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOANNE TURNER', 18)}}的其他基金
Dual Beckman Coulter DxH 690T and Beckman Coulter DxH 560 AL
双贝克曼库尔特 DxH 690T 和贝克曼库尔特 DxH 560 AL
- 批准号:
10431573 - 财政年份:2022
- 资助金额:
$ 6.96万 - 项目类别:
Downstream sample analyses from 3 NHP species infected with SARS-CoV-2.
对感染 SARS-CoV-2 的 3 个 NHP 物种进行下游样本分析。
- 批准号:
10177667 - 财政年份:2016
- 资助金额:
$ 6.96万 - 项目类别:
Exploring the impact of inflammaging on immune function during M. tb infection
探索结核分枝杆菌感染期间炎症对免疫功能的影响
- 批准号:
10004235 - 财政年份:2016
- 资助金额:
$ 6.96万 - 项目类别:
Exploring the impact of inflammaging on immune function during M. tb infection
探索结核分枝杆菌感染期间炎症对免疫功能的影响
- 批准号:
9884698 - 财政年份:2016
- 资助金额:
$ 6.96万 - 项目类别:
Social stress as a co-morbidity of age-associated tuberculosis
社会压力是年龄相关结核病的共病
- 批准号:
9479794 - 财政年份:2016
- 资助金额:
$ 6.96万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 6.96万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 6.96万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 6.96万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 6.96万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 6.96万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 6.96万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 6.96万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 6.96万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 6.96万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 6.96万 - 项目类别: